91 search results for: patient burden

expert video

The Importance of Disease Control in Reducing CSU Patient Burden

2 min

Dermatology

Join Professor Hide as he discusses the importance of disease control in reducing CSU patient burden.

expert video

CSU Burden Related to Chronicity and Patient Journey

2 min

Dermatology

Join Professor Hide as he describes the disease burden and treatment challenges experienced by patients with chronic spontaneous urticaria.

Can Emerging Treatments Help Address Individual PN <b>Patient</b> <b>Burden</b>?

expert video

Can Emerging Treatments Help Address Individual PN Patient Burden?

17 min

Dermatology

Prof. Sonja Ständer emphasizes the high patient burden of PN, and how this is influenced by patient needs and comorbidities. She discusses how emerging treatments are reducing patient burden.

2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our <b>Patient</b>s Video

expert video

2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video

46 min

Type 2 Inflammation

This cross-TA plenary session addressed challenges in type 2 inflammation-driven diseases. Esteemed faculty, including Profs Klaus Rabe, Sharon Dell, Anju Peters, Milli Gupta, Eric Simpson, Stella Lee, and moderator Oscar Palomares, discussed strategies to enhance quality of life, reduce disease burden, and prioritize patient-centered care.

expert video

What We Know About Bullous Pemphigoid (BP): Challenges of the Various Clinical Manifestations, Diagnosis, and Burden for Patients and Caregivers

10 min

Dermatology

In this ADVENT symposium at the 2024 EADV meeting, Professor Joost Meijer highlights the heterogeneous nature of BP and the resultant burden for patients.

Podcast

ADVENT On Air | Pulmonary Perspectives: Understanding COPD Patient Burden

24 min

Pulmonology

Professors Francesca Puggioni and Ian Pavord explore the burdens faced by patients afflicted with Chronic Obstructive Pulmonary Disease (COPD).

Most <b>Burden</b>some Symptoms Rated by PN <b>Patient</b>s

expert video

Most Burdensome Symptoms Rated by PN Patients

1 min

Dermatology

Dr. Chovatiya discusses the impact of pruritus on patients with PN.

Infographic

Prurigo Nodularis (PN): Understanding Its Clinical Features, Complex Burden, and Underlying Mechanisms

2 min

Dermatology

Explore the clinical features, complex burden, and underlying mechanisms of PN.

Explore the Global <b>Burden</b> of Pediatric AD (PEDISTAD)

interactivity

Explore the Global Burden of Pediatric AD (PEDISTAD)

15 min

Dermatology

This interactive tool allows you to explore the global burden of AD in pediatric patients <12 years from the PEDISTAD Study.

ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to <b>Burden</b> and Clinical Management for <b>Patient</b>s with Uncontrolled and/or Severe CRSwNP

expert video

ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP

9 min

Rhinology

Prof. Peter Hellings discusses the interconnection between the pathophysiology, burden and clinical management of uncontrolled and/or severe CRSwNP

interactivity

Uncovering the Impact of Moderate COPD Exacerbations

5 min

Pulmonology

Understand the impact of moderate chronic obstructive pulmonary disease (COPD) exacerbations on future exacerbation risk, lung function decline, mortality, and patient quality of life.

expert video

Blisters and Beyond: Autoimmunity Meets Type 2 Inflammation in Bullous Pemphigoid

12 min

Dermatology

Join Dr. Victoria Werth in exploring the clinical presentation of BP and how type 2 inflammation contributes to the development of disease signs and symptoms

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: PolandChange country/region